Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • amyloid (1)
  • cognitive (1)
  • cognitive impairment (2)
  • diagnosis (2)
  • disease and (1)
  • female (1)
  • humans (1)
  • patient (1)
  • positron (1)
  • presenilin 1 (4)
  • putamen (2)
  • woman (1)
  • Sizes of these terms reflect their relevance to your search.

    A correct clinical diagnosis of motor dysfunction accompanied by cognitive impairment remains challenging. Recent advances in molecular imaging biomarkers hold promise to overcome this issue. A 37-year-old woman presenting with parkinsonism and cognitive impairment underwent both multimodal neuroimaging and genetic testing. Her main findings on PET included diffuse tau accumulation in the cerebral cortex and left putamen, increased cerebellar amyloid deposits, asymmetrically reduced dopamine transporter binding, and mild hypermetabolism in the putamen. Genetic analysis revealed the presence of a presenilin-1 mutation (C.1157T>G). These findings suggested a diagnosis of early-onset autosomal dominant Alzheimer disease accompanied by parkinsonism. Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

    Citation

    Jia-Ying Lu, Yi-Min Sun, Tzu-Chen Yen, Chuan-Tao Zuo, Jian Wang. Multimodal Imaging in a Patient With Alzheimer Disease and Parkinsonism Because of a Presenilin-1 Mutation. Clinical nuclear medicine. 2021 Sep 01;46(9):e483-e484

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33883498

    View Full Text